Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Federal Trade Commission
US Department of Justice
Merck
Johnson and Johnson
Harvard Business School
Cipla
Cerilliant

Generated: September 18, 2018

DrugPatentWatch Database Preview

DIPYRIDAMOLE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dipyridamole, and when can generic versions of Dipyridamole launch?

Dipyridamole is a drug marketed by Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Ani Pharms Inc, Barr, Glenmark Generics, Impax Labs, Lannett Co Inc, Murty Pharms, Oxford Pharms, Purepac Pharm, Watson Labs, and Zydus Pharms Usa Inc. and is included in twenty-two NDAs.

The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.

Drug patent expirations by year for DIPYRIDAMOLE
Pharmacology for DIPYRIDAMOLE
Medical Subject Heading (MeSH) Categories for DIPYRIDAMOLE
Synonyms for DIPYRIDAMOLE
2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)-[1,3]diazino[5,4-d]pyrimidin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol
2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol
2-({6-[bis(2-hydroxyethyl)amino]-4,8-dipiperidylpyrimidino[5,4-d]pyrimidin-2-y l}(2-hydroxyethyl)amino)ethan-1-ol
2-[[2-(bis(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido[6,5-e]pyrimidin-
2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidinyl)-6-pyrimido[5,4-d]pyrimidinyl]-(2-hydroxyethyl)amino]ethanol
2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol;
2,2 ,2 ,2 -(4,8-Dipiperidino- pyrimido [5,4-d] pyrimidine-2,6- diyldinitrilotetraethanol
2,2',2',2'''-((4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol
2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]-pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol
2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethano
2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol
2,2',2'',2'''-((4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetrakis(ethan-1-ol)
2,2',2'',2'''-((4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol
2,2',2'',2'''-(4,8-Dipiperidino-pyrimido [5,4-d] pyrimidine-2,6-diyldinitrilotetraethanol
2,2',2'',2'''-(4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilotetraethanol
2,2',2'',2'''-[(4,8-dipiperidin-1-ylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol
2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol
2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakisethanol
2,2',2'',2'''-{[4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo}tetraethanol
2,2'',2'''-[4,8-Dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilotetraethanol
2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
2,8-dipiperidinopyrimido[5,4-d]pyrimidine
4-26-00-03840 (Beilstein Handbook Reference)
4CA-0464
54290-EP2277865A1
54290-EP2298773A1
54290-EP2305653A1
54290-EP2308562A2
58-32-2
58-32-2,763-39-4(XHCl)
64ALC7F90C
A828156
AB00051974
AB00051974_20
AB00051974_21
AB00051974-18
AB00051974-19
AB0013300
AB2000355
AC-18100
AC1L1F6T
AC1Q7CXU
AC1Q7CXW
AC1Q7CXX
Aggrenox
Agilease
AJ-23813
AK-76609
AKOS000509426
AN-23600
Anginal
Antistenocardin
ANW-49242
Apo-Dipyridamole
Apo-Dipyridamole Fc
Apo-Dipyridamole Sc
Apotex Brand of Dipyridamole
Apricor
Ashbourne Brand of Dipyridamole
B1933
BAS 00818792
BBL027781
BC213273
BCP9000613
BCPP000256
BDBM23620
Belmac Brand of Dipyridamole
Berlin Chemie Brand of Dipyridamole
Berlin-Chemie Brand of Dipyridamole
BIM-0050449.0001
Bio-0173
Boehringer Ingelheim Brand of Dipyridamole
BPBio1_000270
BR-76609
BRD-K86301799-001-04-1
BRD-K86301799-001-24-9
BRN 0068373
BSPBio_000244
BSPBio_001554
BSPBio_001924
C24H40N8O4
Cardioflux
Cardoxil
Cardoxin
CAS-58-32-2
CCG-40190
Cerebrovase
CHEBI:4653
CHEMBL932
Chilcolan
cid_3108
CJ-04389
Cleridium
Cleridium 150
Coribon
Coridil
Coronarine
Corosan
Coroxin
CPD000058382
CS-2352
CTK8B5592
Curantil
Curantyl
D 9766
D00302
D0F9GE
D2274
DB00975
Dipiridamol
Dipiridamol [INN-Spanish]
Dipyramidole
Dipyridamine
Dipyridamol
Dipyridamole (JP15/USP/INN)
Dipyridamole (JP17/USP/INN)
Dipyridamole (Persantine)
Dipyridamole [USAN:INN:BAN:JAN]
Dipyridamole for peak identification, European Pharmacopoeia (EP) Reference Standard
Dipyridamole, >=98% (TLC), powder
Dipyridamole, British Pharmacopoeia (BP) Reference Standard
Dipyridamole, European Pharmacopoeia (EP) Reference Standard
Dipyridamole, United States Pharmacopeia (USP) Reference Standard
Dipyridamolum
Dipyridamolum [INN-Latin]
Dipyridan
Dipyudamine
DivK1c_000696
DR003079
DSSTox_CID_20668
DSSTox_GSID_40668
DSSTox_RID_79531
DTXSID6040668
Dypyridamol
Dypyridamole
EBD20789
EINECS 200-374-7
EN300-70723
Ethanol, 2,2',2',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-
Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-
Ethanol, 2,2',2'',2'''-((4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetra-
Ethanol, 2,2',2'',2'''-(4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyldinitrilo)tetra-
Ethanol, 2,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-
Ethanol,2',2'',2'''-(4,8-dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetra-
Ethanol,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-
Ethanol,2',2'',2'''-[(4,8-dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetra-
EU-0100464
FT-0603242
GTPL4807
Gulliostin
H843
HE356097
HMS1568M06
HMS1791N16
HMS1920I10
HMS1989N16
HMS2089N15
HMS2091O18
HMS2095M06
HMS2232E19
HMS3259C03
HMS3261M10
HMS3266J17
HMS3371J03
HMS3402N16
HMS3655I20
HMS502C18
HS-0041
HY-B0312
IDI1_000696
InChI=1/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2
IPRAD Brand of Dipyridamole
Iv Persantine
IZEKFCXSFNUWAM-UHFFFAOYSA-
IZEKFCXSFNUWAM-UHFFFAOYSA-N
J10379
Justpertin
KBio1_000696
KBio2_001484
KBio2_004052
KBio2_006620
KBio3_001144
KBioGR_001123
KBioSS_001484
KS-00000KNA
Kurantil
Lopac-D-9766
Lopac0_000464
LP00464
LS-66732
MCULE-3112669573
MFCD00010555
Miosen
MLS000028420
MLS001076306
MLS001333724
MLS002548866
MolPort-001-792-504
MP-0582
Natyl
NC00448
NCGC00015385-01
NCGC00015385-02
NCGC00015385-03
NCGC00015385-04
NCGC00015385-05
NCGC00015385-06
NCGC00015385-07
NCGC00015385-08
NCGC00015385-09
NCGC00015385-10
NCGC00015385-11
NCGC00015385-12
NCGC00015385-13
NCGC00015385-14
NCGC00015385-15
NCGC00015385-16
NCGC00015385-18
NCGC00023914-02
NCGC00023914-04
NCGC00023914-05
NCGC00023914-06
NCGC00023914-07
NCGC00023914-08
NCGC00023914-09
NCGC00023914-10
NCGC00023914-11
NCGC00261149-01
NCI60_005689
NINDS_000696
Novo-Dipiradol
Novopharm Brand of Dipyridamole
NSC 515776
NSC-515776
NSC-619103
NSC-756743
NSC515776
NSC756743
Opera_ID_494
Peridamol
Permiltin
Permole
Permole, Persantine, Dipyridan, Dipyridamole
Permole;Dipyridan;Persantine
Persantin
Persantine
Persantine (TN)
Pharmakon1600-01500259
Piroan
Prandiol
Prandiol 75
Prestwick_145
Prestwick0_000142
Prestwick1_000142
Prestwick2_000142
Prestwick3_000142
Protangix
Pyrimido(5, 2,6-bis[bis(2-hydroxyethyl)amino]-4,8-diperidino-
Pyrimido(5,4-d)pyrimidine, 2,6-bis(bis(2-hydroxyethyl)amino)-4,8-dipiperidino-
RA 8
RA-8
RTR-020274
s1895
SAM002264609
SBI-0050449.P004
SC-18455
SCHEMBL16119
SMP2_000208
SMR000058382
SPBio_001003
SPBio_002183
Spectrum_001004
SPECTRUM1500259
Spectrum2_000972
Spectrum3_000402
Spectrum4_000522
Spectrum5_000839
SR-01000003065
SR-01000003065-2
ST078856
ST2415551
Stenocardil
Stenocardiol
Stimolcardio
STL377790
Thymidine,6-dihydro-6-methoxy-
Tocris-0691
Tox21_110133
Tox21_110133_1
Tox21_500464
UNII-64ALC7F90C
UPCMLD-DP072
UPCMLD-DP072:001
Usaf Ge-12
VA10749
W-105400
W1467
WLN: T66 BN DN GN INJ CCN HCN E- AT6NTJ B2Q F2Q& J- AT6NTJ B2Q F2Q
Z1259192074
ZB014732
ZINC643046

US Patents and Regulatory Information for DIPYRIDAMOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-001 Jan 28, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Purepac Pharm DIPYRIDAMOLE dipyridamole TABLET;ORAL 089425-001 Jul 12, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-002 Jan 28, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Purepac Pharm DIPYRIDAMOLE dipyridamole TABLET;ORAL 089426-001 Jul 12, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Athenex Inc DIPYRIDAMOLE dipyridamole INJECTABLE;INJECTION 074939-001 Apr 13, 1998 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Federal Trade Commission
US Department of Justice
Merck
Johnson and Johnson
Harvard Business School
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.